Cue Biopharma, Inc. funding
Cue Biopharma, Inc., a biotechnology company based in Boston, MA, filed a Form D with the SEC on July 22, 2026 and reported $50M raised. It filed 2 new offerings in this period, totaling $80M.
Amount raised$50M
Offering size$50M
Filed with the SECJuly 22, 2026
First saleJuly 13, 2026
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationBoston, MA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far4
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Jul 22
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| July 22, 2026 | $50M | $50M | Equity, Options or warrants, Security to be acquired on exercise |
| May 14, 2026 | $30M | $30M | Options or warrants, Security to be acquired on exercise, Other |
Other health care rounds in Massachusetts
Zai Lab Ltd$250M · Nov 9BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21BiotechnologyAI3 Bio, Inc.$48.3M · Nov 4BiotechnologyNanopath Inc$29.9M · Nov 13BiotechnologyXRHealth, Inc.$22.8M · Sep 16Other Health CareXact Bio, Inc.$10M · Sep 28BiotechnologyCrosslink Therapeutics Inc.$5.5M · Oct 20PharmaceuticalsFresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care